November 3, 2023 News by Marisa Wexler, MS AI tool has potential to better track MS lesions over time: Study An artificial intelligence (AI) program, called iQ-MS, outperforms traditional radiologist-based measures at quantifying changes in lesions over time in people with multiple sclerosis (MS), a new study shows. “iQ-MS is a sensitive and accurate tool for monitoring MRI scans in people with MS by providing quantitative metrics that value-add…
July 5, 2023 News by Lindsey Shapiro, PhD AI algorithms may predict cognitive decline in MS over coming year Researchers have developed computer algorithms that may be able to predict certain aspects of cognitive change in multiple sclerosis (MS) patients. The prediction models, constructed using data from an electronic, self-administered test of information processing speed given MS patients, might accurately identify those likely to experience cognitive worsening over…
June 23, 2023 News by Marisa Wexler, MS Imcyse joins EU project to develop tools to better track MS progression The biopharmaceutical company Imcyse has signed on to a new project that aims to use artificial intelligence (AI) to develop tools that can be used to better track the progression of multiple sclerosis (MS). The project’s goal is to help guide treatment decisions for MS patients. Called Clinical…
May 5, 2023 Columns by Ed Tobias Artificial intelligence moves into the MS exam room. But should it? Is artificial intelligence (AI) intelligent enough to help make a diagnosis of multiple sclerosis (MS)? Apparently so, and more. In the United Kingdom, a project named AssistMS is studying whether AI can be used to detect and highlight changes on brain MRIs. An algorithm software called…
March 9, 2023 News by Lindsey Shapiro, PhD Icobrain MS, an AI tool for assessing MRI scans, being tested in UK An upcoming study will investigate how well icobrain MS, anĀ artificial intelligence (AI)-based technology,Ā can interpret MRI dataĀ from people with multiple sclerosis (MS) and how its use might influence patient care. The project, called AssistMS and led by IcometrixĀ ā the technology’s developer ā and Queen Mary University of London…
November 21, 2022 News by Mary Chapman QData MS Research Platform Aims for Better Patient Treatment, Care With a goal of betterĀ treatment and care for people withĀ multiple sclerosis (MS), Verana Health is developing a neurology module for disease research that includes de-identified and curated real-world data covering more than 30,000 MS patients. The digital health company is developing Qdata MS to…
August 18, 2022 News by Margarida Maia, PhD Eye Scans May Help to Diagnose MS in Children A machine learning approach based on eye scans was employed by researchers to diagnose multiple sclerosis (MS) in children with up to 80% accuracy. Optical coherence tomography (OCT) scans also provided enough data to diagnose other demyelinating diseases with 75% accuracy. OCT is an imaging tool that uses…
July 29, 2022 News by Mary Chapman Cionic Collaborates With Fuseproject on Neural Sleeve Cionic has collaborated with the multidisciplinary design firm fuseproject to further develop its artificial intelligence-powered, wearable Neural Sleeve, which improves mobility for those living with conditions such as multiple sclerosis (MS). The partnership with Yves Behar and his firm fuseproject resulted in a design that focuses on…
July 28, 2022 News by Marta Figueiredo, PhD Calyx, Qynapse to Expand Use of Neuroimaging AI Tools Calyx and Qynapse have joined forces to expand the use of artificial intelligence (AI)-based neuroimaging tools in clinical trials of treatment candidates for conditions affecting the central nervous system (CNS), or the brain and spinal cord. This is expected to help advance therapy development for multiple sclerosis…
July 20, 2022 News by Lindsey Shapiro, PhD Study Aims for Better Way of Marking Myelination in MS Patients Rune Labs has partnered with Coastal Research Institute (CRI) to identify new and noninvasive biomarkers of the loss of myelin, the fatty sheath surrounding nerve fibers that is progressively damaged byĀ multiple sclerosis (MS). The collaboration involves a patient study that will take advantage of Rune Labsā…
June 29, 2022 News by Lindsey Shapiro, PhD OM1 Develops Algorithm to Estimate EDSS Scores OM1 has created an artificial intelligence (AI)-based algorithm to estimate scores on the expanded disability status scale (EDSS), an established method for evaluating disability and disease progression in people with multiple sclerosis (MS). The algorithm, using a method called machine learning, was trained to estimate EDSS scores…
May 2, 2022 News by Marisa Wexler, MS NICE Briefing Covers Icobrain System for Automated MRI Scans The National Institute for Health and Care Evidence (NICE) in England has issued a briefing on the use ofĀ Icometrix‘s icobrain system to assess disease activity in people with multiple sclerosis (MS) based on MRI scans. The NICE statement was in the form of a medtech innovation briefing, or…
December 1, 2021 News by Patricia Inacio, PhD Deal Brings AI-powered MRI to Care of Patients With Brain Disorders A new collaboration between Arterys and Combinostics seeks to bring comprehensive artificial intelligence (AI) imaging solutions to the diagnosis and care of patients with multiple sclerosis (MS) and other neurological diseases. Under the partnership, Arterys will include Combinosticsā AI-powered cNeuro on its medical imaging cloud AI platform…
November 10, 2021 News by Marta Figueiredo, PhD AI Proposed to Help Thwart MS Treatment Delays, Discontinuation Patientsā underestimation of their own disease and the cost and side effects of disease-modifying therapies (DMTs) are among the main causes of delayed treatment initiation and non-adherence in multiple sclerosis (MS) patients, according to a report from OptimizeRx. These findings help uncover areas for improvement, which the health…
November 1, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Mono and MS, Cold and Inflammation, Mesenchymal Stem Cells, MS Smartwatch Mono as Child or Teenager Tied to Risk of MS as Adult in Large Study There’s been a lot of buzz about this study, but I don’t think anyone should be surprised about its results. For years, researchers have suspected a link between the Epstein-Barr virus (EBV) ā the…
October 26, 2021 News by Margarida Maia, PhD Owlytics’ MS Smartwatch Goes Through First Validation Stage Owlytics Healthcare, in partnership with Tel-Aviv Medical Center in Israel, has taken its smartwatch ā designed to monitor symptoms ofĀ multiple sclerosisĀ (MS) from afar ā through a first stage of validation. The smartwatch, worn on the wrist, collects a continuous stream of personal health data that are sent to…
July 16, 2021 News by Mary Chapman OM1 Launches MS Registry for Use in Research, Trial Planning OM1, a technology company focused on chronic conditions, announced that it has launched a multiple sclerosis (MS) registry to generate data that may ultimately be used to improve care and develop treatments for the disease. The OM1 registry is being touted as the largest, most representative MS data…
July 9, 2021 News by Steve Bryson, PhD Cambridge-1 ‘Supercomputer’ to Advance UK Research in Ills Like MS Nvidia announced the launch of the U.K.ās most powerful supercomputer ā calledĀ Cambridge-1 ā which uses a combination of artificial intelligence (AI) and simulation to help scientists to better understand complex diseases such as multiple sclerosis (MS) and to design new therapeutics. Cambridge-1 is the first supercomputer designed…
May 28, 2021 News by Margarida Maia, PhD PicnicHealth, Komodo Pool Real-world Data for Research PicnicHealth and Komodo Health have agreed to combine their databases of patient medical records to support research based on real-world evidence. Together, the companies hope to unlock new insights into complex diseases like multiple sclerosis (MS). āKomodo Health and PicnicHealth share a mission to utilize health data…
April 12, 2021 News by Marisa Wexler, MS MS Has 3 Distinct Subtypes, Study of MRI Brain Patterns Using AI Reports Using artificial intelligence (AI) on imaging data collected from multiple sclerosis (MS) patients, researchers were able to classify these people into three new disease subtypes, each distinct from the current groupings determined byĀ symptoms. These new subtypes may allow doctors to better determine those patients more likely to have…
March 31, 2021 News by Marisa Wexler, MS Machine Learning of Walking Patterns Could Help Predict MS Progression A machine learning-based method that examines walking abnormalities in people with multiple sclerosis (MS) could help identify patients who are at high risk of worsening symptoms, a study suggests. The study, “Predicting Multiple Sclerosis from Gait Dynamics Using an Instrumented Treadmill ā A Machine Learning Approach,”…
February 22, 2021 News by Marta Figueiredo, PhD AI-powered Robotic Glove May Help Improve Hand Grip Strength BioLiberty, a Scottish biotech startup, has developed a robotic glove that uses artificial intelligence (AI) to improve the hand grip in people with muscle weakness due to multiple sclerosisĀ (MS) and other conditions. The technology may be closer to entering peopleās homes now that the startup has secured support…
November 10, 2020 News by David Melamed, PhD Israel Grants Owlytics $1.3M to Develop Wearable AI Device to Improve MS Care The Israeli Innovation Authority has awarded Owlytics Healthcare a $1.3-million grant to support the company’s development of wearable artificial intelligence (AI) technology that has the potential to improve multiple sclerosis (MS) therapies and better evaluate treatment efficacy in clinical studies. The device would be able to continuously…
July 13, 2020 News by Joana Carvalho, PhD University of Sydney Awarded AU$7.1M in Pursuit of Better MS, Mental Health Treatment The Australian Governmentās Medical Research Future Fund (MRFF) has awarded AU$7.1 million (about $4.95 million) to support two projects focused on harnessing the power of artificial intelligence (AI) and machine learning to develop new ways of diagnosing and treatingĀ multiple sclerosis (MS) and mental health disorders in young people.
December 9, 2019 News by Iqra Mumal, MSc Artificial Intelligence and Machine Learning May Help in Understanding MS Cause, Groups Say Combining data science, artificial intelligence (AI), and machine learning to better identify patterns that may underlie the cause or causes of multiple sclerosis (MS) is the focus of a novel partnership. Despite numerous advances in MS research and treatments, what causes the disease is still unknown. “Given the complexity…
December 5, 2019 News by Alice MelĆ£o, MSc $1M Gift to MS Society of Canada to Support New Tools for Better Therapy Decisions TD Bank GroupĀ has donated $1 million to the Multiple Sclerosis (MS) Society of CanadaĀ to support research projects aiming to use artificial intelligence to create tools enabling better use of disease-modifying therapies (DMTs) inĀ multiple sclerosisĀ (MS) patients. MS Society will channel these funds into itsĀ Acts of Greatness campaign,…
May 3, 2019 News by Marisa Wexler, MS #AANAM – Precision Innovative Network and Splice Machine Will Present Predictive Healthcare Application at AAN Meeting A new clinical application prototype that uses machine learning to help physicians predict the best treatment options for patients with multiple sclerosis (MS) will be unveiled at theĀ American Academy of Neurology’s 2019 annual meetingĀ May 4ā10, in Philadelphia, Pennsylvania. The prototype is called PIN Population Data Platform. It has been…
December 3, 2018 Columns by Ed Tobias MS News that Caught My Eye Last Week: MRI Dyes, Lipids and MS, Gilenya Advisory, Possible Stem Cell Trial Artificial Intelligence May Help Reduce Dosage of Gadolinium in MRIs, Researchers Suggest There’s been concernĀ recently about the accumulation of gadolinium in the brains of people who’ve had MRIs. Gadolinium is the dye that’s used to provide the “contrast” that can highlight lesions in the brain that might…
November 28, 2018 News by Alice MelĆ£o, MSc Artificial Intelligence May Help Reduce Dosage of Gadolinium in MRIs, Researchers Suggest Artificial intelligence can help reduce the amount of gadolinium used as a contrast agent in MRI (magnetic resonance imaging) scans, preventing the agent’s potential toxicity when accumulated in body tissue, including the brain and bones, each time it is used, researchers suggest. The finding is of particular importance for…